NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
1.36
-0.17 (-11.11%)
At close: Oct 03, 2025, 3:59 PM
1.36
0.00%
After-hours: Oct 03, 2025, 07:56 PM EDT
-11.11% (1D)
| Bid | 1.36 |
| Market Cap | 7.92M |
| Revenue (ttm) | 4.75M |
| Net Income (ttm) | 3.32M |
| EPS (ttm) | 2.3 |
| PE Ratio (ttm) | 0.59 |
| Forward PE | -4.11 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.44 |
| Volume | 614,816 |
| Avg. Volume (20D) | 7,034,133 |
| Open | 1.55 |
| Previous Close | 1.53 |
| Day's Range | 1.34 - 1.58 |
| 52-Week Range | 0.46 - 4.44 |
| Beta | 0.54 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+72.42%
NovaBay Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
-0.83%
NovaBay Pharmaceuticals shares are trading higher after the company announced a one-time special cash dividend of $0.80 per share.
